Goldman Sachs: “They expect to supply globally up to 50mn vaccine doses in 2020 and manufacture up to 1.3bn doses in 2021. Based on PFE/BNTX dosing schedule each person will require two doses.PFE noted on the company’s 3Q earnings call that they expect to provide 30-40mn doses in the US by the end of 2020 assuming they receive approval and the…[Read more]

Goldman Sachs: GS cross-asset macro conf call yesteday focusing on read-across the election can be summarized like this: “no change”. Nothing to see here, circulate back to CB BS….

Key message is that “our forecasts look about right” and there seems to be very little need to change anything.

Economics: current forecasts look about right. If…[Read more]

Goldman Sachs: Still very long, but not as long as just a few weeks ago. Just shaving, or a start of a significant sector-rotation?

“After significant long buying in September and early October, hedge funds have started to sell FAAMG again Collectively as a group, FAAMG has been net sold in five of the past six days (8 of the past 10) on the GS…[Read more]

Citigroup: “we remain cautious on buying the dip at current levels, preferring instead to wait for more supportive levels around 3,340/11,400 in SPX/NDX where profits are small again.”